申请人:Bellamacina R. Cornelia
公开号:US20070027150A1
公开(公告)日:2007-02-01
2-Amino-quinazolin-5-one compounds, stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-quinazolin-5-one compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the 2-amino-quinazolin-5-one compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cell proliferative diseases.
2-氨基喹唑啉-5-酮化合物,立体异构体,互变异构体,药学上可接受的盐及其前药;包括药学上可接受的载体和一种或多种2-氨基喹唑啉-5-酮化合物的组合物,可以单独使用或与至少一种额外治疗剂结合使用。使用2-氨基喹唑啉-5-酮化合物的方法,可以单独使用或与至少一种额外治疗剂结合使用,用于预防或治疗细胞增殖性疾病。